Literature DB >> 34881399

Fabrication of Stable Apigenin Nanosuspension with PEG 400 as Antisolvent for Enhancing the Solubility and Bioavailability.

Renjie Xu1, Cuiping Jiang2,3, Lijing Zhou1, Bin Li1, Yi Hu1, Yujie Guo4, Xuecheng Xiao5, Shan Lu6.   

Abstract

The purpose of this paper is to prepare a stable apigenin nanosuspension with a drug concentration of 1.11 mg/mL through green and efficient antisolvent method. Compared with the traditional preparation process that may use toxic reagents, in this study, a green and effective strategy was applied for the preparation of stable apigenin nanosuspension by using an antisolvent method with PEG 400 as antisolvent to improve the solubility and bioavailability. It was found that the particle size of apigenin nanosuspension was about 280 nm, and the solubility and dissolution of the nanosuspension were 33 and 3 times higher than that of the apigenin, respectively. Pharmacokinetic study showed that the Cmax and AUC 0-8 h values of the nanosuspension in fasting rats achieved about 6- and 2.5-fold enhancement than that of the apigenin, respectively. Stability test showed that the apigenin nanosuspension could be stored stably for 12 months at 25℃. Taken together, the antisolvent method with PEG 400 was proven to be a green and effective method to prepare the stable nanosuspension of poorly soluble drugs.
© 2021. The Author(s), under exclusive licence to American Association of Pharmaceutical Scientists.

Entities:  

Keywords:  nanosuspension; polyethylene glycol 400; solubility; stability

Mesh:

Substances:

Year:  2021        PMID: 34881399     DOI: 10.1208/s12249-021-02164-x

Source DB:  PubMed          Journal:  AAPS PharmSciTech        ISSN: 1530-9932            Impact factor:   3.246


  1 in total

1.  Formulation and Evaluation of Apigenin-Loaded Hybrid Nanoparticles.

Authors:  Imran Kazmi; Fahad A Al-Abbasi; Syed Sarim Imam; Muhammad Afzal; Muhammad Shahid Nadeem; Hisham N Altayb; Sultan Alshehri
Journal:  Pharmaceutics       Date:  2022-04-03       Impact factor: 6.525

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.